Study Stopped
Funding and resource restrictions.
Electroencephalogram and Attention Deficit Hyperactivity Disorder Study
EEG and ADHD Study
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose of this research is to assess and determine brain oscillations or "brain signatures" of adult participants with Attention Deficit Hyperactivity Disorder (ADHD) relative to adult participants without ADHD using the technique electroencephalogram (EEG). Electroencephalogram is entirely non-invasive way of tracking brain activity.The main goal of this study is to establish biological factors for determining the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 30, 2014
CompletedFirst Posted
Study publicly available on registry
June 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2017
CompletedNovember 7, 2017
November 1, 2017
3.6 years
May 30, 2014
November 3, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Brain Wave Measurements
Measurement of electroencephalogram amplitude and coherence in alpha, gamma, and theta brain wave bands.
Two years
Secondary Outcomes (1)
Default Network Signatures
two years
Other Outcomes (1)
Comparison of dependent measurements between Attention Deficit Hyperactivity Disorder and healthy controls
two years
Study Arms (2)
Attention Deficit Hyperactivity Disorder
This study aims to recruit 100 adult participants: 50 of which are adults diagnosed with Attention Deficit Hyperactivity Disorder and 50 healthy controls. All participants will perform a total of two tasks while connected to electroencephalogram (EEG) sensors; the first task is a resting state task and after that a cognitive challenge task (attention control). Study activity is performed in a single visit which lasts two hours. Participants will also be asked to complete some behavioral questionnaires.
Healthy Control
This study aims to recruit 100 adult participants: 50 of which are adults diagnosed with Attention Deficit Hyperactivity Disorder and 50 healthy controls. All participants will perform a total of two tasks while connected to electroencephalogram (EEG) sensors; the first task is a resting state task and after that a cognitive challenge task (attention control). Study activity is performed in a single visit which lasts two hours. Participants will also be asked to complete some behavioral questionnaires.
Interventions
The electroencephalogram assesses brain electrical activity through surface recording disks (electrodes) which are placed near the participants' head using a custom designed Lycra cap. The electrodes transmit the signals which are then amplified and stored on a computer. The procedure is entirely non-invasive. Once an accurate signal is assured, the signal derived from the electrode cap is then amplified, transmitted to a computer, and stored for later analysis. Each participant will undergo the electroencephalogram (EEG) procedure only once for the duration of 30-45 minutes.
Eligibility Criteria
100 adult participants will be recruited for this study: 50 adults diagnosed with Attention Deficit Hyperactivity Disorder and 50 healthy controls.
You may qualify if:
- Right-handedness
- Currently unmedicated adults with ADHD. To be given a full diagnosis of adult ADHD, the participant must have full Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-R) criteria: (1) described a chronic course of ADHD symptomatology from childhood to adulthood, and (2) endorsed a moderate or sever level of impairment attributed to the ADHD symptoms.
You may not qualify if:
- Currently taking psychoative medications
- Any clinically significant neurological problem (e.g., tics, seizures, serious head injury)
- Alcohol or substance abuse (current or in the past 2 years)
- Any current Axis I psychiatric diagnosis (other than ADHD) as verified by clinical interview
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rachel Upjohn Building
Ann Arbor, Michigan, 48109-2700, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chandra S Sripada, MD, PhD
University of Michigan
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chandra Sekhar Sripada, MD, PhD
Study Record Dates
First Submitted
May 30, 2014
First Posted
June 3, 2014
Study Start
February 1, 2014
Primary Completion
September 15, 2017
Study Completion
September 15, 2017
Last Updated
November 7, 2017
Record last verified: 2017-11